SEARCH HEALTH CONDITIONS BY ALPHABETS
Anemia, Megaloblastic
Medications for Anemia, Megaloblastic
Other names: Megaloblastic Anemia
Around Anemia, Megaloblastic: Megaloblastic anemia is a blood disorder characterized by anemia, with red blood cells that are larger than normal, usually leading to a lack of folic acid or of vitamin b 12.
Drugs Used in the Treatment of Anemia, Megaloblastic
This set of medications have been somehow related to, or found in the treatment of this condition.
| Drug title | Rx / OTC | Pregnancy | CSA | Alcohol | Reviews | Rating | Popularity |
|---|---|---|---|---|---|---|---|
| folic acid | Rx/OTC | A | N | Insert inspection | 6.5 | ||
Generic title: folic acid blossom Brand names: Folacin-800, FA-8 Drug class: vitamins For users: dosage, interactions, For specialists: a Z Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
| Folacin-800 | Rx/OTC | A | N | Insert inspection | 0.0 | ||
Generic title: folic acid blossom Drug class: vitamins For users: dosage, interactions, side effects | |||||||
| Wellcovorin | Rx | C | N | Insert inspection | 0.0 | ||
Generic title: leucovorin systemic Drug course: antidotes For users: dosage, interactions, side effects For specialists: AHFS DI Monograph | |||||||
| leucovorin | Rx | C | N | Insert inspection | 0.0 | ||
Generic title: leucovorin systemic Brand title: Wellcovorin Drug course: antidotes For users: dosage, interactions, For specialists: a Z Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
| FA-8 | Rx/OTC | A | N | Insert inspection | 0.0 | ||
Generic title: folic acid blossom Drug class: vitamins For users: dosage, interactions, side effects | |||||||
Issues under Anemia, Megaloblastic
- B12 Nutritional Deficiency (11 drugs)
- Folic Acid Deficiency (8 drugs)
- Folic Acid/Cyanocobalamin Deficiency (0 drugs)
- Pernicious Anemia (2-4 drugs in two topics)
Legend
| Rx | prescription-only |
|---|---|
| OTC | Over the Counter |
| Rx/OTC | Prescription or Over The Counter |
| Away Prizes | This drug may well not be approved by the FDA for the treatment of this condition. |
| Pregnancy Category | |
|---|---|
| A | sufficient and well-controlled studies have failed to demonstrate a risk to the fetus within the first trimester of pregnancy (and there isn`t any evidence of risk in later trimesters). |
| B | Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no sufficient and well-controlled studies in elderly women. |
| C | Animal research studies have demonstrated a negative effect in the fetus and there are no sufficient and well-controlled studies in humans, but potential benefits may warrant used in pregnant women despite potential risks. |
| D | There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant used in pregnant women despite potential risks. |
| X | Studies in animals or humans have demonstrated fetal abnormalities and/or there`s positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and also the risks involved with used in elderly women clearly outweigh potential rewards. |
| N | FDA have not classified this drug. |
| Controlled Substances Act (CSA) Schedule | |
|---|---|
| N | isn`t at the mercy of the Controlled Substances Act. |
| 1 | Has a higher possibility of misuse. Has no currently accepted medical use in treatment in the United States. There`s a lack of accepted safety for use under medical supervision. |
| 2 | Has a higher possibility of misuse. Has a currently accepted medical use with severe restrictions or a currently accepted medical use in treatment in the United States. Abuse may cause severe psychological or physical dependency. |
| 3 | features a potential for abuse less than individuals in programs 1 and 2 two. Has a currently accepted medical use in treatment in the United States. Abuse may lead to physical dependence or high psychological dependence. |
| 4 | Has a very low potential for abuse in accordance with individuals in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to individuals in schedule 3. |
| 5 | Has a very low potential for abuse in accordance with individuals in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to individuals in schedule 4. |
| Infection | |
|---|---|
| X | Interacts with Alcohol. |
Browse Treatment Plans
- A
- B
- C
- D
- E
- F
- G
- H
- I
- J
- K
- L
- M
- N
- O
- P
- Q
- Janin
- S
- T
- U
- V
- W
- X
- Y
- Z
Further info
Always consult your healthcare provider to be sure the information displayed on this page applies to your circumstances.
Top USA Pharma Companies
Popular Categories
Easily find an affordable health insurance plan
